Authors:
Constantin Lucian Alexandru, Constantin Mirela Alina, Nitoi Ines, Galaon Toma, Cristea Ionut
Constantin Lucian Alexandru, Constantin Mirela Alina, Nitoi Ines, Galaon Toma, Cristea Ionut
Conference: International Symposium “The Environment and the Industry”
Date: 26-27 September 2019
Location: Bucharest, Romania
Published: 2019
Keywords:
Flutamide
Photocatalyse
TiO2
Abstract:
Flutamide, 2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-propanamide (FT) is nonsteroidal androgen drug used mainly for treatment of prostate cancer, but also for transgender hormone therapy and skin and hair conditions. There is available very limited information on FT degradation using advanced oxidation processes (AOPs), In fact, to our knowledge only one study is available which used direct photolysis, UV/H2O2 and UV/S2O82− systems and concluded that FT degradation was not very effective pointed out the need to consider also other advanced oxidation processes and/or a combination of them. In this aim, a preliminary screening of FT degradation via TiO2 assisted photocatalyse was performed. The main photocatalyse parameters that were investigated were the photo catalyst dose and irradiation time.
